<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Mercado Riggs | Activity</title>
	<link>https://recash.wpsoul.net/members/makeuptoad37/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/makeuptoad37/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Mercado Riggs.</description>
	<lastBuildDate>Tue, 19 May 2026 23:40:29 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">d95d5e8dcafd13cdaeadb67f16d1c58d</guid>
				<title>Mercado Riggs posted an update: Introduction The successful development of anti-inflammatory [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/53118/</link>
				<pubDate>Wed, 11 Dec 2024 17:37:30 +0000</pubDate>

									<content:encoded><![CDATA[<p>Introduction The successful development of anti-inflammatory disease-modifying treatments (DMT) significantly improved disease outcomes and longevity of persons with multiple sclerosis (pwMS). However, the shift toward an elderly MS population has resulted with new concerns regarding DMT efficacy and safety.Areas covered This review summarizes the&hellip;<span class="activity-read-more" id="activity-read-more-53118"><a href="https://recash.wpsoul.net/activity/p/53118/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e9e7c2c35596b83f7fa6b9956f775fd1</guid>
				<title>Mercado Riggs became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/52885/</link>
				<pubDate>Wed, 11 Dec 2024 17:17:11 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>